Pfizer Inc. (LON:0Q1N)
London flag London · Delayed Price · Currency is GBP · Price in USD
26.10
+0.10 (0.38%)
At close: Feb 21, 2025

Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of GBP 117.90 billion. The enterprise value is 163.99 billion.

Market Cap 117.90B
Enterprise Value 163.99B

Important Dates

The last earnings date was Tuesday, February 4, 2025.

Earnings Date Feb 4, 2025
Ex-Dividend Date Jan 24, 2025

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) -0.16%
Shares Change (QoQ) -0.04%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 5.66B

Valuation Ratios

The trailing PE ratio is 18.38.

PE Ratio 18.38
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 25.56
EV / Sales 3.26
EV / EBITDA 8.87
EV / EBIT 12.62
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.73
Debt / EBITDA 2.92
Debt / FCF n/a
Interest Coverage 5.28

Financial Efficiency

Return on equity (ROE) is 8.85% and return on invested capital (ROIC) is 6.28%.

Return on Equity (ROE) 8.85%
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 6.28%
Return on Capital Employed (ROCE) n/a
Revenue Per Employee 577,538
Profits Per Employee 72,897
Employee Count 88,000
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -6.12% in the last 52 weeks. The beta is 0.57, so Pfizer's price volatility has been lower than the market average.

Beta (5Y) 0.57
52-Week Price Change -6.12%
50-Day Moving Average 26.22
200-Day Moving Average 27.85
Relative Strength Index (RSI) 52.17
Average Volume (20 Days) 130,050

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 1.84

Income Statement

In the last 12 months, Pfizer had revenue of GBP 50.82 billion and earned 6.41 billion in profits. Earnings per share was 1.13.

Revenue 50.82B
Gross Profit 37.71B
Operating Income 13.04B
Pretax Income 6.41B
Net Income 6.41B
EBITDA 18.59B
EBIT 13.04B
Earnings Per Share (EPS) 1.13
Full Income Statement

Balance Sheet

The company has 7.95 billion in cash and 54.27 billion in debt, giving a net cash position of -46.32 billion.

Cash & Cash Equivalents 7.95B
Total Debt 54.27B
Net Cash -46.32B
Net Cash Per Share n/a
Equity (Book Value) 73.93B
Book Value Per Share 13.01
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 74.19%, with operating and profit margins of 25.66% and 12.62%.

Gross Margin 74.19%
Operating Margin 25.66%
Pretax Margin 12.61%
Profit Margin 12.62%
EBITDA Margin 36.57%
EBIT Margin 25.66%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 1.33, which amounts to a dividend yield of 5.10%.

Dividend Per Share 1.33
Dividend Yield 5.10%
Dividend Growth (YoY) 1.57%
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield 0.16%
Shareholder Yield 5.26%
Earnings Yield 5.44%
FCF Yield n/a
Dividend Details

Stock Splits

The last stock split was on July 1, 1999. It was a forward split with a ratio of 3.

Last Split Date Jul 1, 1999
Split Type Forward
Split Ratio 3

Scores

Altman Z-Score n/a
Piotroski F-Score n/a